Speech-Language Pathologists in Crestview Hills, KY Accepting Medicare

16 Speech-Language Pathologists found. Showing 1 - 16

Crista Yeager, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 859-426-5666

Ms. Stephanie Bright, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr Ste 105, Crestview Hills, KY 41017 Phone: 859-426-5666

Lauren Elizabeth Ford Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Crestview Hills, KY 41017 Phone: 859-426-5666

Janet Dea Hackett Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 859-426-5666    Fax: 859-426-5665

Ms. Leigha Brooke Ochsner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy Ste 102, Crestview Hills, KY 41017 Phone: 859-426-5666

Mrs. Debra Lynn Way, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 856-426-5666    Fax: 856-426-5665

Ms. Jacqueline Sue Adams, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 859-426-5666    Fax: 859-426-5665

Jessica Leigh Sayre Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy, Crestview Hills, KY 41017 Phone: 859-426-5666

Mrs. Elizabeth Irene Carleton-scheper, M.S. CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, 105, Crestview Hills, KY 41017 Phone: 859-426-5666    Fax: 859-426-5665

Benjamin Lisker Chernoff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy Ste 102, Crestview Hills, KY 41017 Phone: 859-426-5666

Gail Walsh, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Ste 105, Crestview Hills, KY 41017 Phone: 859-426-5666    Fax: 859-426-5665

Megan Kathleen Grainger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy Ste 102, Crestview Hills, KY 41017 Phone: 859-426-5666

Michelle Hoban, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr Ste 105, Crestview Hills, KY 41017 Phone: 859-426-5666    Fax: 859-426-5665

Mrs. Leah Rumford, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy Ste 102, Crestview Hills, KY 41017 Phone: 859-426-5666

Kathy R Mount, MS, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2765 Chapel Pl, Crestview Hills, KY 41017 Phone: 859-344-4749    Fax: 859-344-0770

Miss Kara Taylor, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2765 Chapel Pl # 6004, Crestview Hills, KY 41017 Phone: 859-344-4511

News Archive

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

A world of consequences due to physical inactivity

Physical inactivity accounted for an estimated 5.3 million of the 57 million deaths in 2008, a report shows.

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Alpha cells in the pancreas, which do not produce insulin, can convert into insulin-producing beta cells, advancing the prospect of regenerating beta cells as a cure for type 1 diabetes. The findings come from a study at the University of Geneva, co-funded by the Juvenile Diabetes Research Foundation, that is published today in the online edition of the scientific journal Nature.

U.S District Court grants preliminary approval for the settlement of Sampson v. Robinson case

Bristol-Myers Squibb Company (NYSE:BMY) announced today that the United States District Court for the Southern District of New York has granted preliminary approval of settlement of Sampson v. Robinson, et al., Case No. 1:07-CV-06890 (on appeal: Case No. 08-5475), a shareholder action pursued derivatively on behalf of Bristol-Myers Squibb. The action concerned allegations relating to the efforts to settle the Plavix patent litigation in 2006. The proposed settlement is subject to final Court approval. The Court has set a final approval hearing for December 8, 2009 at 2 p.m. in the courtroom of the Honorable Paul A. Crotty, United States District Judge.

Read more Medical News

› Verified 4 days ago